semaj83/ctmatch_classification huggingface dataset:
Patient description: A 42-year-old healthy woman came to the clinic to have her flu shot in early October. She works in a rehab center and has no underlying disease. It's her first time getting the vaccine this year. She is married for 5 years and uses barrier methods of contraception. Her menstrual cycle is irregular. She does not smoke. She is not on any medications. She exercises regularly for 30 minutes a day at least 5 days a week. She has no history of allergies to any food or drugs. Her past surgical history is significant for tonsillectomy and she is otherwise healthy.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Neoplasms, Malignant Breast Neoplasm Carcinoma, Basal Cell Carcinoma, Squamous Cell Melanoma Skin Neoplasm Head and Neck Neoplasms Subject must be capable of giving informed consent or has an acceptable surrogate capable of giving consent on behalf of the subject. 2. Subject has an eligible tumor that is within 5 mm of the surface (either skin or mucosa) or has had a tumor removed with a tumor bed that is within 5 mm of the surface. 1. Eligible tumors types Intraoral tumors: squamous cell carcinoma (SCC), melanoma Primary cutaneous tumors (including, but not limited to): SCC, basal cell carcinoma (BCC,) melanoma Breast malignancies post surgery Other tumors: any tumor within 5 mm of the surface and with planned radiation therapy  Previous adverse reaction to a charcoal product e.g., a local hypersensitive response from a black tattoo or from ingestion of activated charcoal 2. Previous adverse reaction to the suspending agent 3. Subject has a pacemaker that is not known to be MRI compatible 4. Subject has a non-removable implant or device with metal that is not known to be MRI compatible 5. Subject is pregnant or has a likelihood for becoming pregnant during the basic study timeframe. Note: There is no known harm to the woman or her fetus from participating; this is precautionary only
Patient description: A 42-year-old healthy woman came to the clinic to have her flu shot in early October. She works in a rehab center and has no underlying disease. It's her first time getting the vaccine this year. She is married for 5 years and uses barrier methods of contraception. Her menstrual cycle is irregular. She does not smoke. She is not on any medications. She exercises regularly for 30 minutes a day at least 5 days a week. She has no history of allergies to any food or drugs. Her past surgical history is significant for tonsillectomy and she is otherwise healthy.

Clinical trial eligibility criteria: eligible ages (years): 3.0-13.0,  Tonsillitis Healthy patients aged 3-13 years Level I or level II on the American Society of Anesthesiologists (ASA) physical status classification system (as determined by the anesthesiologist) obstructive sleep apnea or recurrent throat infections undergoing elective tonsillectomy with or without adenoidectomy Parents who agree to complete documentation and follow up at 14 days post-operation  Patients Level III or greater on the American Society of Anesthesiologists (ASA) physical status classification system (as determined by the anesthesiologist) Patients with chronic conditions that would limit our ability to develop the study according to objectives, such as neurodevelopmental conditions preventing patients from understanding the Oucher tool Hepatic or renal disease cardiac disease active infection diabetes mellitus sickle cell disease known coagulation disorders pre operative treatment with anti-emetics, steroids, or analgesics
Patient description: A 42-year-old healthy woman came to the clinic to have her flu shot in early October. She works in a rehab center and has no underlying disease. It's her first time getting the vaccine this year. She is married for 5 years and uses barrier methods of contraception. Her menstrual cycle is irregular. She does not smoke. She is not on any medications. She exercises regularly for 30 minutes a day at least 5 days a week. She has no history of allergies to any food or drugs. Her past surgical history is significant for tonsillectomy and she is otherwise healthy.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Influenza Solid Organ Transplant Kidney, liver or pancreas transplant recipients on at least one immunosuppressive medication Age ≥ 18 Outpatient status Greater than 30 days post-transplant  Has already received influenza vaccination for 2017-2018 season Egg allergy or allergy to previous influenza vaccine Febrile illness in the past one week Active Cytomegalovirus viremia Use of Rituximab in the past one year Ongoing or recent (in past 30 days) therapy for acute rejection Chronic kidney insufficiency (creatinine clearance ≤30mL/min or dialysis-dependent Previous life-threatening reaction to influenza vaccine (i.e., Guillain Barre Syndrome) Receipt of intravenous immunoglobulin (IVIG) in the past 30 days or planning to receive IVIG in the next four weeks
Patient description: A 42-year-old healthy woman came to the clinic to have her flu shot in early October. She works in a rehab center and has no underlying disease. It's her first time getting the vaccine this year. She is married for 5 years and uses barrier methods of contraception. Her menstrual cycle is irregular. She does not smoke. She is not on any medications. She exercises regularly for 30 minutes a day at least 5 days a week. She has no history of allergies to any food or drugs. Her past surgical history is significant for tonsillectomy and she is otherwise healthy.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Influenza, Human Patient of client organizations of Emmi Solutions Provided a phone number to their care team
Patient description: A 42-year-old healthy woman came to the clinic to have her flu shot in early October. She works in a rehab center and has no underlying disease. It's her first time getting the vaccine this year. She is married for 5 years and uses barrier methods of contraception. Her menstrual cycle is irregular. She does not smoke. She is not on any medications. She exercises regularly for 30 minutes a day at least 5 days a week. She has no history of allergies to any food or drugs. Her past surgical history is significant for tonsillectomy and she is otherwise healthy.

Clinical trial eligibility criteria: eligible ages (years): 20.0-999.0,  Acne Vulgaris Patient with acne, with at least 10 inflammatory lesions and no more than 3 nodules Patient who already had one cycline course for her acne treatment with a 3 months* wash out or who never had any cycline Patient having signed an informed consent Absence of use of oral antibiotics and Zinc salts in the last 30 days Absence of use of systemic isotretinoin and antiandrogens in the last 6 months Absence of microphysiotherapy in the last 15 da Women of child-bearing age under contraception since 3 months (oral contraception, implant or IUD) Patients with social security  Patient affected by active /progressive diseases, as infections including Hidradenitis suppurativa, cancers, or endocrine syndrome (eg polycystic ovary syndrome), Addison's disease) Patient affected by Rosacea Patient with contra-indication to the use of one of the investigational products or auxiliary  Patient with intolerance or hypersensitivity to cyclin's, spironolactone or to any ingredient present in associated benzoyl peroxide gel Patient with significant impairment of renal excretory function, acute or chronic renal failure, anuria Patient with life-threatening or very severe hepatic impairment.(grade III or IV) Patient with hyperkalaemia or strongly requiring potassium-sparing diuretics (eg amiloride, canrenoate, eplerenone, triamterene), or treated continuously with Angiotensin-converting-enzyme (ACE) inhibitors, angiotensin II antagonist, NSAIDs, heparin and molecular weight heparin, ciclosporin and tacrolimus Patient requiring topical isotretinoin or who stopped this drug since less than 2 weeks Patient previously treated with spironolactone Pregnant woman or likely to become pregnant or nursing and refusing to use an effective contraceptive method
Patient description: A 42-year-old healthy woman came to the clinic to have her flu shot in early October. She works in a rehab center and has no underlying disease. It's her first time getting the vaccine this year. She is married for 5 years and uses barrier methods of contraception. Her menstrual cycle is irregular. She does not smoke. She is not on any medications. She exercises regularly for 30 minutes a day at least 5 days a week. She has no history of allergies to any food or drugs. Her past surgical history is significant for tonsillectomy and she is otherwise healthy.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Thoracoabdominal Aneurysm patient with ≥ 18 years of age, undergoing total endovascular treatment of thoracoabdominal pathology (single-stage or multi-stage endovascular repair) at San Raffaele Hospital in between October 2013 and December 2020  none
Patient description: A 42-year-old healthy woman came to the clinic to have her flu shot in early October. She works in a rehab center and has no underlying disease. It's her first time getting the vaccine this year. She is married for 5 years and uses barrier methods of contraception. Her menstrual cycle is irregular. She does not smoke. She is not on any medications. She exercises regularly for 30 minutes a day at least 5 days a week. She has no history of allergies to any food or drugs. Her past surgical history is significant for tonsillectomy and she is otherwise healthy.

Clinical trial eligibility criteria: eligible ages (years): 18.0-59.0,  Influenza Flu Aged ≥ 18 to 59 years on the day of Informed consent form has been signed and dated Able to attend all scheduled visits and to comply with all trial procedures  Subject is pregnant, or lactating, or of childbearing potential and not using an effective method of contraception or abstinence from at least 4 weeks prior to vaccination until at least 4 weeks after vaccination. To be considered of non- childbearing potential, a female must be post-menopausal for at least 1 year or surgically sterile Participation at the time of study enrollment (or in the 4 weeks preceding the trial vaccination) or planned participation during the present trial period in another clinical trial investigating a vaccine, drug, medical device, or medical procedure Receipt of any vaccine or planned receipt of any vaccine within the period from 2 weeks before trial vaccination to 2 weeks following trial vaccination Previous vaccination against influenza (in the previous 6 months) with either the trial vaccines or another vaccine Receipt of immune globulins, blood or blood-derived product in the past 3 months Known or suspected congenital or acquired immunodeficiency; or receipt of immunosuppressive therapy, such as anti-cancer chemotherapy or radiation therapy, within the preceding 6 months; or long-term systemic corticosteroid therapy (prednisone or equivalent for more than 2 consecutive weeks within the past 3 months) Known systemic hypersensitivity to any of the vaccines components, or history of a life-threatening reaction to the vaccines used in the trial or to a vaccine containing any of the same substances Self-reported thrombocytopenia contraindicating intramuscular vaccination Bleeding disorder, or receipt of anticoagulants in the 3 weeks preceding contraindicating intramuscular vaccination Deprived of freedom by an administrative or court order, or in an emergency setting, or hospitalized involuntarily
Patient description: A 42-year-old healthy woman came to the clinic to have her flu shot in early October. She works in a rehab center and has no underlying disease. It's her first time getting the vaccine this year. She is married for 5 years and uses barrier methods of contraception. Her menstrual cycle is irregular. She does not smoke. She is not on any medications. She exercises regularly for 30 minutes a day at least 5 days a week. She has no history of allergies to any food or drugs. Her past surgical history is significant for tonsillectomy and she is otherwise healthy.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Procedural Bleeding Delayed Bleeding Post-Polypectomy Syndrome Post Procedural Complication Sex and age: men and women > 18 years old 2. Subjects referred for EMR of polyps of size ≥11 mm 3. ASA score 1, 2 or 3. 4. Contraception: Women of childbearing potential must have a negative pregnancy test (one is provided as the standard of care) or sign a waiver. Post-menopausal women must have been in that status for at least 1 year (per standard of care). 5. Subject is willing and able to participate in the study procedures and to understand and sign the informed consent  Age: Subjects is under 18 years old 2. Consent: Vulnerable subjects including those who are unable to consent 3. Pregnancy: Pregnant or breastfeeding women 4. ASA score <3 5. Physical findings: Abnormal physical findings that may interfere with the study objectives 6. Study participation: Subjects currently participating in another clinical study or previously enrolled in another clinical study in the last 30 days 7. Excluded lesions Lesions less than 11 mm in largest dimension Lesions involving the muscularis propria (T2 lesions) Ulcerated depressed lesions (Paris type III) or pathology proven invasive carcinoma Proven malignant disease locally advanced or with metastasis Active inflammatory bowel disease lesion, e.g ulcerative colitis, Crohn's disease Endoscopic appearance of invasive malignancy 8. Previous partial resection or attempted resection of the lesion 9. Allergy: Proven or potential allergic reaction to study products or history of anaphylaxis to drugs 10. Severe liver disease. 11. Known or suspected gastrointestinal obstruction or perforation, active diverticulitis, toxic megacolon, 12. Inflammatory bowel disease e.g ulcerative colitis or Crohn's disease 13. Hemostasis disorders (eg Von Willebrand disease, factor V Leiden thrombophilia or haemophilia), known clotting disorder (INR>1.5). 14. Subject with any other current serious medical conditions that would increase the risks associated with taking part in the study. 15. Patients must be advised to stop anticoagulation medications prior to the procedure per local practice guidelines and should re-start as clinically indicated after the procedure
Patient description: A 42-year-old healthy woman came to the clinic to have her flu shot in early October. She works in a rehab center and has no underlying disease. It's her first time getting the vaccine this year. She is married for 5 years and uses barrier methods of contraception. Her menstrual cycle is irregular. She does not smoke. She is not on any medications. She exercises regularly for 30 minutes a day at least 5 days a week. She has no history of allergies to any food or drugs. Her past surgical history is significant for tonsillectomy and she is otherwise healthy.

Clinical trial eligibility criteria: eligible ages (years): 20.0-85.0,  Inflammation Men and women between the ages of 20-35 years Men and women between the ages of 65-85 years  Regular use of omega-3 nutritional supplements Diabetes or fasting plasma glucose > or equal to 126 mg/dL Anemia (female subjects hemoglobin of <11 g/dl and male subjects hemoglobin <12 g/dl) Active coronary artery disease or history of unstable macrovascular disease (unstable angina, myocardial infarction, stroke, and revascularization of coronary, peripheral or carotid artery within 3 months of recruitment) Renal failure (serum creatinine > 1.5mg/dl) Chronic active liver disease (AST>144 IU/L or ALT>165 IU/L) Oral warfarin group medications or history of blood clotting disorders international normalized ratio (INR) >2.01.5 Smoking Pregnancy or breastfeeding
Patient description: A 42-year-old healthy woman came to the clinic to have her flu shot in early October. She works in a rehab center and has no underlying disease. It's her first time getting the vaccine this year. She is married for 5 years and uses barrier methods of contraception. Her menstrual cycle is irregular. She does not smoke. She is not on any medications. She exercises regularly for 30 minutes a day at least 5 days a week. She has no history of allergies to any food or drugs. Her past surgical history is significant for tonsillectomy and she is otherwise healthy.

Clinical trial eligibility criteria: eligible ages (years): 18.0-65.0,  Cardiovascular Diseases Depression Ability to give informed consent Fluent in English Between the ages of 18-65 Lives in the United States Self-report of having experienced depression as assessed by the Mini International Neuropsychiatric Interview (MINI) Self report an elevated risk for or of having cardiovascular disease ( >150 minutes of physical activity a week and BMI >25) Registered a personal account with Fitbit prior to enrollment in the study  Unwilling/unable to comply with study procedures Pregnant A total score of a 20 on the PHQ-9 (indicative of "very severe" depression) and/or a total score of a 16 on the ASRM (or indicative of "very severe" mania) Responds to item 9 (Suicidal ideation) on the PHQ-9 with a 2 or higher (i.e., "Thoughts that you would be better off dead or of hurting yourself in some way on more than half the days") Contraindications to exercise or diet interventions as assessed by the DASI Already owns a fitbit device or other activity monitor Suffers from repeated episodes of "blacking out" or "fainting" Survived a cardiac arrest or sudden death Has recurrent chest discomfort with activity that goes away within 10 minutes of rest or with nitroglycerin Has heart failure
Patient description: A 42-year-old healthy woman came to the clinic to have her flu shot in early October. She works in a rehab center and has no underlying disease. It's her first time getting the vaccine this year. She is married for 5 years and uses barrier methods of contraception. Her menstrual cycle is irregular. She does not smoke. She is not on any medications. She exercises regularly for 30 minutes a day at least 5 days a week. She has no history of allergies to any food or drugs. Her past surgical history is significant for tonsillectomy and she is otherwise healthy.

Clinical trial eligibility criteria: eligible ages (years): 18.0-49.0,  Influenza Age 18-49 years old on the day of screening, having Thai ID card or equivalent Able to read and write in Thai and sign written informed consent form Able to attend all scheduled visits and to comply with all trial procedures Healthy or medically stable, as established by medical history and physical examination. For individuals with medical conditions, symptoms/signs, if present must be stable, under control or unchanged for the past three months. If medication is used to treat the condition, the medication dose must have been stable for at least one month preceding vaccination For female participants Not breast feeding, non-pregnant (based on negative urine pregnancy test) and no plan to become pregnant up to Day 60 Women who are not surgically sterile (hysterectomy or tubal ligation) or post-menopausal for more than one year must be willing to use effective contraceptive method to prevent pregnancy until Day 60 after vaccination. Effective methods intrauterine device, hormonal contraceptives (oral, injectable, patch, implant, ring) or double barrier contraceptives (condom or diaphragm with spermicide). Women with credible history of abstinence may be enrolled at the discretion of the investigator  Participation in another clinical trial involving any therapy within the previous three months or planned enrollment in such a trial during the period of this study Hypersensitivity after previous administration of any vaccine Having a history of H1N1, H3N2 or Flu B infection within 3 months preceding enrollment to the trial Vaccination against influenza in the past 6 months preceding enrollment to the trial Receipt of any non-study vaccine within four weeks prior to enrollment or refusal to postpone receipt of such vaccines until after the Day 21 visit History of bronchial asthma, chronic lung diseases, chronic rhinitis History of immunodeficiency state History of immunosuppression < 6 months prior to immunization History of anaphylactic or other allergic reactions to influenza vaccine or any vaccine component or excipient (e.g. gentamicin or thimerosal) History of Guillain-Barré Syndrome
Patient description: A 42-year-old healthy woman came to the clinic to have her flu shot in early October. She works in a rehab center and has no underlying disease. It's her first time getting the vaccine this year. She is married for 5 years and uses barrier methods of contraception. Her menstrual cycle is irregular. She does not smoke. She is not on any medications. She exercises regularly for 30 minutes a day at least 5 days a week. She has no history of allergies to any food or drugs. Her past surgical history is significant for tonsillectomy and she is otherwise healthy.

Clinical trial eligibility criteria: eligible ages (years): 18.0-45.0,  Recurrent Pregnancy Loss Unexplained Infertility Inclusion/  Recurrent Pregnancy Loss Age 18-45 or more SABs including biochemical pregnancies OR 2 or more SABs if one is documented to be euploid irregular menstrual cycles Submucosal fibroid >3cm Stage 3-4 endometriosis BMI >40 IUD within the last 3 months 2. Unexplained infertility Patients TTC x >= 1 year At least one SA with TMS >10 mil within last 2 years
Patient description: A 42-year-old healthy woman came to the clinic to have her flu shot in early October. She works in a rehab center and has no underlying disease. It's her first time getting the vaccine this year. She is married for 5 years and uses barrier methods of contraception. Her menstrual cycle is irregular. She does not smoke. She is not on any medications. She exercises regularly for 30 minutes a day at least 5 days a week. She has no history of allergies to any food or drugs. Her past surgical history is significant for tonsillectomy and she is otherwise healthy.

Clinical trial eligibility criteria: eligible ages (years): 18.0-40.0,  Obesity Exercise Reinforcement Participants must be overweight to obese (BMI 25-35 kg/m2) Not pregnant or lactating or planning to become pregnant in the next 6 months No limitations to safely participating in physical activity  Currently dieting to lose weight and no weight loss or gain >2kg over the past 3 months Taking any medications that affect energy expenditure or eating Regularly exercising (planned and structured aerobic or resistance activity) Participants must have no major health problems, cannot have known cardiovascular (cardiac, peripheral vascular, cerebrovascular), pulmonary (COPD, interstitial lung disease, cystic fibrosis) or metabolic (diabetes, thyroid disorders, renal or liver disease) disease Tobacco use Have a medical condition that prevents safe exercise